Journal of pharmacological sciences

Tilianin before injury may improve heart cell energy and reduce damage in rats through AMPK/SIRT1/PGC-1 alpha pathway

Updated

Abstract

Tilianin significantly reduced myocardial infarction in a rat model of ischemia/reperfusion injury.

  • Treatment with Tilianin improved the pathological structure of the heart tissue.
  • Tilianin markedly increased ATP and NAD levels while decreasing ADP and AMP levels.
  • The ratio of AMP to ATP was reduced following Tilianin treatment.
  • Tilianin lowered levels of reactive oxygen species (ROS) and malondialdehyde (MDA), indicating reduced oxidative stress.
  • Enhanced activity of superoxide dismutase (SOD) was observed with Tilianin treatment.
  • Expression levels of AMPK, SIRT1, and PGC-1 alpha mRNA were significantly elevated by Tilianin.

Simplified

Full Text

Full text is available at the source.

Funding

No funding data available.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free